Sweden
We chase the miracles of science to improve people's lives
Our progress brings us together and drives us to grow, learn and collectively push our limits. What do we mean by scientific miracles? For us, it means medical breakthroughs that lead to a significant improvement in patients' lives. In practice, it means that we focus our resources where the need is greatest and where the greatest potential to improve lives and protect public health exists.
Our Swedish office is located on Kungsholmen in Stockholm and employs around 150 people.
Sanofi in the world
+90 000
Mer än 90 000 anställda
90
Operating in more than 90 countries
100 years
Over 100 years of experience in innovation and research
Working with us
Forbes named us the second best employer in our industry in 2022. Start your career with us today.
Discover new career opportunities
Our therapeutic areas
Diabetes and cardiovascular diseases
Are you living with diabetes?
If you are living with diabetes, please visit our patient website insulin.se which is full of relevant information and support for those living with diabetes.
Immunology
Are you living with atopic eczema, asthma or nasal polyps?
If you are living with an atopic disease such as atopic dermatitis, asthma or nasal polyps, please visit our patient website atopiker.se which is full of relevant information and support for those living with these diseases.
Vaccines
Want to know more about vaccination?
Please visit our website vaccininfo.se which is full of relevant information for those who want to know more about flu vaccines, childhood vaccines, travel vaccines and much more.
Oncology Talks
Listen to our podcast "Immuno Oncology Talks".
Our oncology portfolio currently includes treatments in prostate cancer and blood cancer.
Neurology
Are you living with multiple sclerosis (MS)?
If you are living with multiple sclerosis (MS), please visit our patient website ms-guiden.se which is full of relevant information and support for those living with MS.
Rare diseases
Are you living with a rare disease?
If you are living with a rare disease such as Fabry disease, Gaucher disease, Pompe disease, MPS1, TTP or thyroid cancer, please visit our patient website rarediseases.com which is full of relevant information and support for those living with these diseases.
Reporting of value transfers
Collaboration between the pharmaceutical industry and healthcare professionals benefits patients. This collaboration has resulted in many innovative medicines and has changed the way many diseases affect our lives.1
EFPIA
Shaping the future of research
Collaboration between industry, healthcare professionals and healthcare organizations is essential to enable the development and effective use of new medicines and to shape the future of research. Bringing greater transparency to these already well-regulated relationships aims to increase understanding of the collaboration between industry, healthcare professionals and healthcare organizations.
As a member company of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Sanofi discloses data on its collaborations with healthcare professionals and healthcare organizations across Europe, including value transfers for activities such as research and education costs, consultancy fees, consultancy overheads and costs related to events targeting healthcare professionals.
Sanofi in Sweden is part of Läkemedelsindustriföreningen (LIF) which is a trade association for research-based pharmaceutical companies operating in Sweden. The Swedish reporting of collaborations with healthcare professionals and healthcare organizations takes place in LIF's collaboration database. It also reports annually on collaborations between pharmaceutical companies and various interest groups such as patient associations, disability associations and patients/relatives.
The LIF cooperation database
The cooperation database was created in 2005 and currently consists of four different sections:
- Stakeholder organizations
- Patient/relatives
- Development projects with healthcare organizations
- Transparent reporting of transfers of value to the health care system.
For more information and to view Sanofi's reporting, visit the LIF website.